Interferon beta-1b Subcutaneous and Tafenoquine (Prevention of Malaria Relapse)
Determining the interaction of Interferon beta-1b Subcutaneous and Tafenoquine (Prevention of Malaria Relapse) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: interferon beta-1b
Brand name: Betaseron, Extavia
Synonyms: Interferon beta-1b, Interferon Beta-1b
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Interferon beta-1b Subcutaneous-Tafenoquine Succinate (Arakoda)
- Interferon beta-1b Subcutaneous-Tafenoquine Succinate (Krintafel)
- Interferon beta-1b Subcutaneous-Tafinlar
- Interferon beta-1b Subcutaneous-Tafluprost
- Interferon beta-1b Subcutaneous-Tafluprost ophthalmic
- Interferon beta-1b Subcutaneous-Tagamet
- Tafenoquine (Prevention of Malaria Relapse)-Interferon Gamma
- Tafenoquine (Prevention of Malaria Relapse)-Interferon gamma Subcutaneous, Injection
- Tafenoquine (Prevention of Malaria Relapse)-Interferon gamma-1b
- Tafenoquine (Prevention of Malaria Relapse)-Intermezzo
- Tafenoquine (Prevention of Malaria Relapse)-Intralipid
- Tafenoquine (Prevention of Malaria Relapse)-Intrarosa